# Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury

> **NCT04331002** · PHASE2 · TERMINATED · sponsor: **Austin V Stone** · enrollment: 1 (actual)

## Conditions studied

- Tibial Meniscus Injuries
- Tibial Meniscus Tears
- Tibial Meniscus, Torn
- Anterior Cruciate Ligament Tear

## Interventions

- **DRUG:** Zilretta
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04331002
- **Lead sponsor:** Austin V Stone
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-08-21
- **Primary completion:** 2022-07-11
- **Final completion:** 2022-07-11
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Funding Termination
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04331002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04331002, "Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04331002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*